Avenue Therapeutics Inc.

AI Score

0

Unlock

1.91
0.03 (1.60%)
At close: Jan 15, 2025, 12:16 PM

Avenue Therapeutics Inc. Forecast

Stock Price Forecast

The 1 analysts with 12-month price forecasts for ATXI stock have an median target of 56.25, with a low estimate of 56.25 and a high estimate of 56.25. The median target predicts an increase of 2845.03% from the current stock price of 1.91.

Analyst Consensus: Buy
Target Low Average Median High
Price $56.25 $56.25 $56.25 $56.25
Change 2845.03% 2845.03% 2845.03% 2845.03%

AI Analyst Report

According to 1 stock analyst, the rating for Avenue Therapeutics Inc. is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.

Rating Dec 23
Strong Buy 0
Buy 1
Hold 0
Sell 0
Strong Sell 0
Total 1

Financial Forecast this Year

Revenue This Year
190.70M
from 0
Increased by -%
Revenue Next Year
258.96M
from 190.70M
Increased by 35.8%
EPS This Year
-6.24
from -73.6
Increased by 91.5%
EPS Next Year
-1.96
from -6.24
Increased by 68.6%